{"id":28649,"date":"2023-01-09T12:35:29","date_gmt":"2023-01-09T10:35:29","guid":{"rendered":"https:\/\/www.asperbio.com\/?page_id=28649"},"modified":"2024-06-27T13:00:58","modified_gmt":"2024-06-27T10:00:58","slug":"koostooprojektid","status":"publish","type":"page","link":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/","title":{"rendered":"Koost\u00f6\u00f6projektid"},"content":{"rendered":"<h2><span style=\"font-size: 12pt;\">Koost\u00f6\u00f6projektid<\/span><\/h2>\n<p>Koost\u00f6\u00f6- ja arendusprojektid on ettev\u00f5tte igap\u00e4evase t\u00f6\u00f6 osaks.<img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-29255 alignright\" src=\"https:\/\/www.asperbio.com\/wp-content\/uploads\/kaks-logo-est_vertical-blue_white-7-140x300.webp\" alt=\"\" width=\"140\" height=\"300\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>AB teekaart (DEP.1.01.24- 0088)<\/strong><\/p>\n<ul>\n<li>Asper Biogene k\u00fcberturvalisuse teekaardi koostamist perioodil 1.04-31.05.2024 kaasrahastas Euroopa K\u00fcberkompetentsikeskus oma liikmetega.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>EU48695 projekt CCHT<br \/>\n<\/strong><\/p>\n<p>Perioodil 1.12.2020 kuni 31.12.2023 osales Asper Biogene kahes alamprojektis:<\/p>\n<ul>\n<li>Rakendusuuringus, kus eesm\u00e4rgiks on genoomika testidel p\u00f5hinevate personaalmeditsiini lahenduste v\u00e4ljat\u00f6\u00f6tamine komplekshaiguste (metaboolsed haigused, kardiovaskulaarhaigused, infertiilsus, jt) ennetuseks ja raviks.<\/li>\n<li>Tootearendusprojektis, mille eesm\u00e4rgiks on personaalmeditsiini genoomika rakendustele sobivaimate kommertslahenduste leidmine.<\/li>\n<li>T\u00f6id tehti Ettev\u00f5tluse Arendamise Sihtasutuse ja Euroopa Liit Euroopa Regionaalarengu Fondi toel.<\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-26353 size-medium\" src=\"https:\/\/www.asperbio.com\/wp-content\/uploads\/EAS_SF_RGB_EST_small-300x83.png\" alt=\"\" width=\"300\" height=\"83\" srcset=\"https:\/\/www.asperbio.com\/wp-content\/uploads\/EAS_SF_RGB_EST_small-300x83.png 300w, https:\/\/www.asperbio.com\/wp-content\/uploads\/EAS_SF_RGB_EST_small.png 400w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Koost\u00f6\u00f6projektid Koost\u00f6\u00f6- ja arendusprojektid on ettev\u00f5tte igap\u00e4evase t\u00f6\u00f6 osaks. &nbsp; AB teekaart (DEP.1.01.24- 0088) Asper Biogene k\u00fcberturvalisuse teekaardi koostamist perioodil 1.04-31.05.2024 kaasrahastas Euroopa K\u00fcberkompetentsikeskus oma liikmetega. &nbsp; &nbsp; &nbsp; &nbsp; EU48695 projekt CCHT Perioodil 1.12.2020 kuni 31.12.2023 osales Asper Biogene kahes alamprojektis: Rakendusuuringus, kus eesm\u00e4rgiks on genoomika testidel p\u00f5hinevate personaalmeditsiini lahenduste v\u00e4ljat\u00f6\u00f6tamine komplekshaiguste (metaboolsed haigused, [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-28649","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Koost\u00f6\u00f6projektid Koost\u00f6\u00f6- ja arendusprojektid on ettev\u00f5tte igap\u00e4evase t\u00f6\u00f6 osaks. AB teekaart (DEP.1.01.24- 0088) Asper Biogene k\u00fcberturvalisuse teekaardi koostamist perioodil 1.04-31.05.2024 kaasrahastas Euroopa K\u00fcberkompetentsikeskus oma liikmetega. EU48695 projekt CCHT Perioodil 1.12.2020 kuni 31.12.2023 osales Asper Biogene kahes alamprojektis: Rakendusuuringus, kus eesm\u00e4rgiks on genoomika testidel p\u00f5hinevate personaalmeditsiini lahenduste v\u00e4ljat\u00f6\u00f6tamine komplekshaiguste (metaboolsed haigused,\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.asperbio.com\/et\/koostooprojektid\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/koostooprojektid\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/koostooprojektid\\\/#listItem\",\"name\":\"Koost\\u00f6\\u00f6projektid\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/koostooprojektid\\\/#listItem\",\"position\":2,\"name\":\"Koost\\u00f6\\u00f6projektid\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/#organization\",\"name\":\"Asper Biogene - genetic testing company\",\"description\":\"with a set of efficient DNA tests\",\"url\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/koostooprojektid\\\/#webpage\",\"url\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/koostooprojektid\\\/\",\"name\":\"Koost\\u00f6\\u00f6projektid | Asper Biogene\",\"description\":\"Koost\\u00f6\\u00f6projektid Koost\\u00f6\\u00f6- ja arendusprojektid on ettev\\u00f5tte igap\\u00e4evase t\\u00f6\\u00f6 osaks. AB teekaart (DEP.1.01.24- 0088) Asper Biogene k\\u00fcberturvalisuse teekaardi koostamist perioodil 1.04-31.05.2024 kaasrahastas Euroopa K\\u00fcberkompetentsikeskus oma liikmetega. EU48695 projekt CCHT Perioodil 1.12.2020 kuni 31.12.2023 osales Asper Biogene kahes alamprojektis: Rakendusuuringus, kus eesm\\u00e4rgiks on genoomika testidel p\\u00f5hinevate personaalmeditsiini lahenduste v\\u00e4ljat\\u00f6\\u00f6tamine komplekshaiguste (metaboolsed haigused,\",\"inLanguage\":\"et\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/koostooprojektid\\\/#breadcrumblist\"},\"datePublished\":\"2023-01-09T12:35:29+02:00\",\"dateModified\":\"2024-06-27T13:00:58+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/\",\"name\":\"Asper Biogene - genetic testing company\",\"description\":\"with a set of efficient DNA tests\",\"inLanguage\":\"et\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.asperbio.com\\\/et\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Koost\u00f6\u00f6projektid | Asper Biogene","description":"Koost\u00f6\u00f6projektid Koost\u00f6\u00f6- ja arendusprojektid on ettev\u00f5tte igap\u00e4evase t\u00f6\u00f6 osaks. AB teekaart (DEP.1.01.24- 0088) Asper Biogene k\u00fcberturvalisuse teekaardi koostamist perioodil 1.04-31.05.2024 kaasrahastas Euroopa K\u00fcberkompetentsikeskus oma liikmetega. EU48695 projekt CCHT Perioodil 1.12.2020 kuni 31.12.2023 osales Asper Biogene kahes alamprojektis: Rakendusuuringus, kus eesm\u00e4rgiks on genoomika testidel p\u00f5hinevate personaalmeditsiini lahenduste v\u00e4ljat\u00f6\u00f6tamine komplekshaiguste (metaboolsed haigused,","canonical_url":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.asperbio.com\/et\/#listItem","position":1,"name":"Home","item":"https:\/\/www.asperbio.com\/et\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/#listItem","name":"Koost\u00f6\u00f6projektid"}},{"@type":"ListItem","@id":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/#listItem","position":2,"name":"Koost\u00f6\u00f6projektid","previousItem":{"@type":"ListItem","@id":"https:\/\/www.asperbio.com\/et\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/www.asperbio.com\/et\/#organization","name":"Asper Biogene - genetic testing company","description":"with a set of efficient DNA tests","url":"https:\/\/www.asperbio.com\/et\/"},{"@type":"WebPage","@id":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/#webpage","url":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/","name":"Koost\u00f6\u00f6projektid | Asper Biogene","description":"Koost\u00f6\u00f6projektid Koost\u00f6\u00f6- ja arendusprojektid on ettev\u00f5tte igap\u00e4evase t\u00f6\u00f6 osaks. AB teekaart (DEP.1.01.24- 0088) Asper Biogene k\u00fcberturvalisuse teekaardi koostamist perioodil 1.04-31.05.2024 kaasrahastas Euroopa K\u00fcberkompetentsikeskus oma liikmetega. EU48695 projekt CCHT Perioodil 1.12.2020 kuni 31.12.2023 osales Asper Biogene kahes alamprojektis: Rakendusuuringus, kus eesm\u00e4rgiks on genoomika testidel p\u00f5hinevate personaalmeditsiini lahenduste v\u00e4ljat\u00f6\u00f6tamine komplekshaiguste (metaboolsed haigused,","inLanguage":"et","isPartOf":{"@id":"https:\/\/www.asperbio.com\/et\/#website"},"breadcrumb":{"@id":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/#breadcrumblist"},"datePublished":"2023-01-09T12:35:29+02:00","dateModified":"2024-06-27T13:00:58+03:00"},{"@type":"WebSite","@id":"https:\/\/www.asperbio.com\/et\/#website","url":"https:\/\/www.asperbio.com\/et\/","name":"Asper Biogene - genetic testing company","description":"with a set of efficient DNA tests","inLanguage":"et","publisher":{"@id":"https:\/\/www.asperbio.com\/et\/#organization"}}]}},"aioseo_meta_data":{"post_id":"28649","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-01-09 10:34:24","updated":"2025-06-04 02:20:22","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.asperbio.com\/et\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tKoost\u00f6\u00f6projektid\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.asperbio.com\/et\/"},{"label":"Koost\u00f6\u00f6projektid","link":"https:\/\/www.asperbio.com\/et\/koostooprojektid\/"}],"_links":{"self":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/comments?post=28649"}],"version-history":[{"count":3,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28649\/revisions"}],"predecessor-version":[{"id":29260,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28649\/revisions\/29260"}],"wp:attachment":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/media?parent=28649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}